News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Aranda Richard
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/09/2023 |
4
| Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns:
| Disposed/sold 45,000 options to buy
@ $22.1, valued at
$994.5k
Disposed/sold 13,750 options to buy
@ $16.4, valued at
$225.5k
Disposed/sold 34,175 options to buy
@ $14.55, valued at
$497.2k
Disposed/sold 60,000 options to buy
@ $9.79, valued at
$587.4k
Disposed/sold 30,000 options to buy
@ $8.47, valued at
$254.1k
Disposed/sold 190,000 options to buy
@ $11.94, valued at
$2.3M
Granted 30,000 options to buy
@ $0 Granted 9,167 options to buy
@ $0 Granted 22,784 options to buy
@ $0 Granted 40,000 options to buy
@ $0 Granted 20,000 options to buy
@ $0 |
|
03/22/2023 |
4
| Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns:
| Granted 157,500 options to buy
@ $1.21, valued at
$190.6k
|
|
03/20/2023 |
4
| Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns:
| Sold 7,563 shares
@ $1.098, valued at
$8.3k
|
|
12/09/2022 |
4
| Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns:
| Granted 157,500 options to buy
@ $2.16, valued at
$340.2k
|
|
10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/10/2022 |
4
| Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns:
| Granted 190,000 options to buy
@ $11.94, valued at
$2.3M
|
|
10/26/2021 |
4
| Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns:
| Sold 2,377 shares
@ $12.25, valued at
$29.1k
|
|
06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|